Not applicableStudy completedNCT00341601What this trial is testingMulti-Drug Resistant Tuberculosis in KoreaWho this might be right forTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 777
Testing effectiveness (Phase 2)Study completedNCT00910871What this trial is testingTo Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.Who this might be right forTuberculosis Janssen Infectious Diseases BVBA 241
Not applicableStudy completedNCT03470233What this trial is testingPost Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TBWho this might be right forMulti-drug Resistant Tuberculosis Korea Otsuka Pharmaceutical Co., Ltd. 149
Not applicableStudy completedNCT07058233What this trial is testingOral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical TrialWho this might be right forTuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb RSUP Persahabatan 70
Large-scale testing (Phase 3)Study completedNCT02342886What this trial is testingShortening Treatment by Advancing Novel DrugsWho this might be right forTuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant Global Alliance for TB Drug Development 284
Large-scale testing (Phase 3)Study completedNCT03086486What this trial is testingVarious Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more Global Alliance for TB Drug Development 181
Testing effectiveness (Phase 2)Study completedNCT02573350What this trial is testingA Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683Who this might be right forTuberculosis, Multidrug-Resistant Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Large-scale testing (Phase 3)Looking for participantsNCT06905522What this trial is testingA PAN-USR TB Multi-Center TrialWho this might be right forPulmonary Tuberculosis Shenzhen Third People's Hospital 610
Not applicableApproved For MarketingNCT01464762What this trial is testingEarly Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary TuberculosisWho this might be right forTuberculosis Janssen Infectious Diseases BVBA
Not applicableStudy completedNCT02729532What this trial is testingEffect of Xpert MTB/RIF on Patient OutcomesWho this might be right forTuberculosis University of North Carolina, Chapel Hill 776
Not applicableStudy completedNCT03822156What this trial is testingClinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH CohortWho this might be right forTuberculosisTuberculosis, PulmonaryCavity+5 more University of Ulsan 500
Testing effectiveness (Phase 2)Study completedNCT04608955What this trial is testingEvaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081Who this might be right forPulmonary Tuberculosis Shanghai Jiatan Pharmatech Co., Ltd 99
Early research (Phase 1)UnknownNCT03575299What this trial is testingClinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT CellsWho this might be right forMulti-drug Resistant Tuberculosis Zhinan Yin, Ph.D. 45
Post-approval studies (Phase 4)UnknownNCT06476210What this trial is testingThe Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Who this might be right forPulmonary Tuberculosis Beijing Chest Hospital 45
Not applicableNot Yet RecruitingNCT06674291What this trial is testingRegistry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)Who this might be right forTuberculosis, Multidrug-Resistant Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Study completedNCT04207112What this trial is testingEconomic Evaluation of New MDR TB RegimensWho this might be right forMulti-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses Medecins Sans Frontieres, Netherlands 73
Early research (Phase 1)Study completedNCT04493671What this trial is testingEvaluate Safety, Tolerability, PK of TBAJ-876 in Healthy AdultsWho this might be right forPulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more Global Alliance for TB Drug Development 137
Large-scale testing (Phase 3)Study completedNCT02607449What this trial is testingFS-1 Drug for Treatment of Multiple Drug-resistant TuberculosisWho this might be right forTuberculosis, MDR Scientific Center for Anti-infectious Drugs, Kazakhstan 344
Testing effectiveness (Phase 2)Study completedNCT02193776What this trial is testingTo Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.Who this might be right forTuberculosis Global Alliance for TB Drug Development 240
Large-scale testing (Phase 3)WithdrawnNCT01600963What this trial is testingEvaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium TuberculosisWho this might be right forMulti-drug Resistant Tuberculosis Janssen Infectious Diseases BVBA